Active Immunization Study of Colon Cancer Derived 1-8D Peptide in HHD Mice |
Jung, Hun-Soon
(School of Life and Food Sciences, Handong Global University)
Ahn, In-Sook (School of Life and Food Sciences, Handong Global University) Do, Hyung-Ki (School of Life and Food Sciences, Handong Global University) Lemonnier, Francois A. (AIDS-retrovirus Department, Antiviral Cellular Unit, Pasteur Institute) Song, Kuk-Hyun (Department of the General Surgery, Handong Global University Sunlin Hospital) Do, Myoung-Sool (School of Life and Food Sciences, Handong Global University) |
1 | Kerr D: Clinical development of gene therapy for colore cancer. Nat Rev Cancer 3;615-622, 2003 DOI PUBMED ScienceOn |
2 | Lewin AR, Reid LE, McMahon M, Stark GR, Kerr 1M: M ecular analysis of a human interferon-inducible gene family. Eur J Biochem 199;417-423, 1991 DOI ScienceOn |
3 | Firat H, Tourdot S, Ureta-Vidal A, Scardino A, Suhrbie Buseyne F, Riviere Y, Danos O, Michel ML, Kosrnatopou K, Lemonnier FA: Design of a polyepitope construct for induction of HLA-A0201-restricted HIV 1-specific CTL sponses using HLA-A*0201 transgenic, H-2 class I KO mice. Eur J Immunol 10;3064-3074, 2001 |
4 | Passoni L, Scardino A, Bertazzoli C, Gallo B, Coluccia A Lemonnier FA, Kosmatopoulos K, Gambacorti-Passerini ALK as a novel lymphoma-associated tumor antigen: ident cation of 2 HLA-A2.1-restricted CD8 + T-cell epitopes. Blood 99;2100-2106, 2002 DOI ScienceOn |
5 | Paglia P, Chiodoni C, Rodolfo M, Colombo MP: Murine dritic cells loaded in vitro with soluble protein prime cyto T lymphocytes against tumor antigen in vivo. J Exp Med 183;317-322, 1996 DOI ScienceOn |
6 | Bellone M, Cantarella D, Castiglioni P, Crosti MC, Ronc A, Moro M, Garancini MP, Casorati G, Dellabona P: R vance of the tumor antigen in the validation of three vac nation strategies for melanoma. J Immunol 165;2651-26 2000 PUBMED |
7 | Brinster C, Muguet S, Lone YC, Boucreux D, Renard Fournillier A, Lemonnier F, Inchauspe G: Different hepa C virus nonstructural protein 3 (Ns3)-DNA-expressing v cines induce in HLA-A2.1 transgenic mice stable cytoto T lymphocytes that target one major epitope. Hepatology 34;1206-1217, 2001 DOI ScienceOn |
8 | Zhang L, Zhou W, Velculescu VE, Kern SE, Hruban R Hamilton SR, Vogelstein B, Kinzler KW: Gene express profiles in normal and cancer cells. Science 276;1268-127 1997 DOI PUBMED ScienceOn |
9 | Thurner B, Haendle L Roder C, Dieckmann D, Keikavo P, Jonuleit H, Bender A, Maczek C, Schreiner D, von Driesch P, Brocker EB, Steinman RM, Enk A, Kampgen Schuler G: Vaccination with mage-3A1 peptide-pulsed ma re, monocyte-derived dendritic cells expands specific cy toxic T cells and induces regression of some metastases advanced stage IV melanoma. J Exp Med 190;1669-167 1999 DOI |
10 | Schreurs MW, Eggert AA, de Boer AJ, Vissers JL, van H T, Offringa R, Figdor CG, Adema GJ: Dendritic cells br tolerance and induce protective immunity against a mela cyte differentiation antigen in an autologous melanoma model. Cancer Res 60;6995-7001, 2000 PUBMED |
11 | Livak KJ, Schmittzen TD: Analysis of relative gene exp ssion data using real-time quantitative PCR and the 2(-De Delta C(T)) method. Methods 25;402-408, 2001 DOI ScienceOn |
12 | Scardino A, Alves P, Gross DA, Tourdot S, Graff-Dub S, Angevin E, Firat H, Chouaib S, Lemonnier F, Nadler L Cardoso AA, Kosmatopoulos K: Identification of HER-neu immunogenic epitopes presented by renal cell carcino and other human epithelial tumors. Eur J Immunol 11;32 3270, 2001 |
13 | Scardino A, Gross DA, Alves P, Schultze JL. Graff-Dub S, Faure O, Tourdot S, Chouaib S, Nadler LM, Lemonn FA, Vonderheide RH, Cardoso AA, Kosmatopoulos HER-2/neu and hTERT cryptic epitopes as novel targets broad spectrum tumor immunotherapy. J Immunol 168;59 5906, 2002 |
14 | Celluzzi CM, Mavordomo JI, Storkus WJ, Lotze MT, LD Jr: Peptide-pulsed dendritic cells induce antigen-speci CTL-mediated protective tumor immunity. J Exp Med 183; 283-287, 1996 DOI ScienceOn |
15 | Gimmi C, Morrison BW, Mainorice BA. Gribben JG, Bo siotis VA. Freeman GJ, Park SY, Watanabe M, Gong Hayes DF, Kufe DW, Nadler LM: Breast cancer associat antigen DF3/MUC-1 induces apoptosis of activated hum T cells. Nat Med 2;1367-1370, 1999 DOI ScienceOn |
16 |
Carmon L, Bobilev-Priel I, Brenner B, Bobilev D, Paz A, B Haim E, Tirosh B, Klein T, Fridkin M, Lemonnier F, Tze val E, Eisenbach L Characterization of novel breast carcin rna-associated BA46-derived oeptides in HLA-A2.1/D(b)- |
17 | Nestle FO, Alijagic S, Gilliet M, Sun Y, Grabbe S, Dum R, Burg G, Schadendorf D: Vaccination of melanoma oa ents with peptide- or tumor lysate-pulsed dendritic cells. Nat Med 4;328-332, 1998 DOI ScienceOn |
18 | Jung HS, Ahn IS, Do HK, Lemonnier FA, Tirosh B, T hoval E, Vadai E, Eisenbach L, Do MS: Adoptive Trans of Colon Cancer Derived Peptide-specific CD8 + T Cells HHD Mice. Immune Netw 4;31-37, 2004 DOI |
19 | Young JW, Inaba K: Dendritic cells as adjuvants for cl I major histocompatibility complex-restricted antitumor munity. J Exp Med 183;7-11, 1996 DOI ScienceOn |
20 | Pascolo S, Bervas N, Ure JM, Smith AG, Lemonnier F Perarnau B: HLA-A2.1-restricted education and cytoly activity of CD8 (+) T lymphocytes from beta 2 microglob (beta2 m) HLA-A2.1 mono chain transgenic H-2Db beta 2 double knockout mice. J Exp Med 185;2043-2051, 1997 DOI ScienceOn |
21 | Graff-Dubois S, Faure O, Gross DA, Alves P, Scardino Chouaib S, Lemonnier FA, Kosmatopoulos K: Generation CTL recognizing an HLA-A*0201-restricted epitope sha by MAGEA1,-A2, -A3, -A4, -A6, -A10, and -A12 tumor a tigens: implication in a broad-spectrum tumor immunot rapy. J Immunol 169;575-580, 2002 PUBMED |
22 | Firat H, Garcia-Pons F, Tourdot S, Pascolo S, Scardino Garcia Z, Michel ML, Jack RW, Jung G, Kosmatopoulos Mateo L, Suhrbier A, Lemonnier FA, Langlade-Demoyen H-2 class I knockout, HLA-A2.1-transgenic mice: a versa animal model for preclinical evaluation of antitumor im notheraoeutic strategies. Eur J Immunol 29;3112-3121, 1999 DOI ScienceOn |
![]() |